Prosecution Insights
Last updated: April 17, 2026
Application No. 16/677,707

AUTONOMOUS SEGMENTATION OF THREE-DIMENSIONAL NERVOUS SYSTEM STRUCTURES FROM MEDICAL IMAGES

Final Rejection §Other
Filed
Nov 08, 2019
Examiner
PIHULIC, DANIEL T
Art Unit
3645
Tech Center
3600 — Transportation & Electronic Commerce
Assignee
Augmedics, Inc.
OA Round
2 (Final)
87%
Grant Probability
Favorable
3-4
OA Rounds
2y 6m
To Grant
80%
With Interview

Examiner Intelligence

Grants 87% — above average
87%
Career Allow Rate
875 granted / 1004 resolved
+35.2% vs TC avg
Minimal -7% lift
Without
With
+-6.7%
Interview Lift
resolved cases with interview
Typical timeline
2y 6m
Avg Prosecution
46 currently pending
Career history
1050
Total Applications
across all art units

Statute-Specific Performance

§101
3.4%
-36.6% vs TC avg
§103
37.2%
-2.8% vs TC avg
§102
31.0%
-9.0% vs TC avg
§112
11.1%
-28.9% vs TC avg
Black line = Tech Center average estimate • Based on career data from 1004 resolved cases

Office Action

§Other
DETAILED ACTION The present Office action supersedes the previous Office action. Withdrawal of Allowance Applicant is advised that the allowability of the present application, previously determined on November 2, 2022, has been withdrawn in view of the reasons set forth in the present Office action. Rejection under 35 U.S.C. § 185 Patent barred for filing without a license The following is a quotation of 35 U.S.C. § 185 that forms the basis for the rejection under this section made in this Office action: Notwithstanding any other provisions of law any person, and his successors, assigns, or legal representatives shall not receive a United States patent for an invention if that person, or his successors, assigns, or legal representatives shall, without procuring the license prescribed in section 184, have made, or consented to or assisted another's making, application in a foreign country for a patent or for the registration of a utility model, industrial design, or model in respect of the invention. A United States patent issued to such person, his successors, assigns, or legal representatives shall be invalid, unless the failure to procure such license was through error, and the patent does not disclose subject matter within the scope of section 181. The invention(s) disclosed in the instant application and all of the presently pending claims are rejected for failing to obtain a foreign filing license as required by 35 U.S.C. § 184 prior to filing the foreign application(s) identified in applicant’s petition seeking a retroactive foreign filing license under 37 CFR § 5.25, which was filed July 15, 2024. Applicant’s petition under 37 CFR § 5.25 was not granted for the reasons provided in the Decision mailed by the Office of Petitions on January 7, 2025. Conclusion The above noted deficiencies cannot be rectified by filing of a continuation, continued prosecution application (CPA), or other types of continuing applications because a patent on the invention disclosed is barred under 35 U.S.C. § 185 for failing to obtain a license as prescribed in 35 U.S.C. § 184 prior to filing application for patent or registration of a utility model, industrial design, or model in respect of the invention in another country. Likewise, filing a Request for Continued Examination (RCE) under 37 CFR § 1.114 will be ineffective to overcome the bar to patentability pursuant to 35 U.S.C. § 185. According to USPTO records to date, the following applications are continuing applications with respect to the instant application: 17708907; 18770492; and 18942266. The Federal Circuit has affirmed the USPTO’s authority to deny a patent on prosecution laches grounds. See Section 2190, I of the Manual of Patent Examining Procedure (MPEP). Abandoning the instant application without overcoming the rejection under 35 U.S.C. § 185 will likely result in a prosecution laches rejection in any continuing application claiming the benefit of the filing date of the instant application. See id; see also MPEP § 201.02 (defining continuing application). No claims are allowed. This Office action is FINAL. Applicant is reminded of the extension of time policy as set forth in 37 CFR § 1.136(a). A shorted statutory period for reply to this final action is set to expire THREE MONTHS from the mailing date of this action. In the event a first reply is filed within TWO MONTHS of the mailing date of this final action and the advisory action is not mailed until after the end of the THREE-MONTH shortened statutory period, then the shortened statutory period will expire on the date the advisory action is mailed, and any extension fee pursuant to 37 CFR § 1.136(a) will be calculated from the mailing date of the advisory action. In no event, however, will the statutory period for reply expire later than SIX MONTHS from the mailing date of this final action. An applicant whose claim(s) has/have been twice rejected may appeal to the Patent Trial and Appeal Board by filing a notice of appeal and the required fee set forth in 37 CFR § 41.20(b)(1) within the time period provided under 37 CFR § 1.134 and 1.136. See MPEP § 1204, II (citing Ex Parte Lemoine, 46 USPQ2d 1420, 1423 (Bd. Pat. App. & Inter. 1994)). Inquiries Any inquiry concerning this the Office action should be directed to Supervisory Patent Examiner Timothy Collins whose telephone number is (571)272-6886. Supervisory Patent Examiner Timothy Collins can normally be reached Monday-Thursday between 5am to 2pm. Any inquiry concerning the decision of Applicant’s petition submitted under 35 U.S.C. § 184 should be directed to Ramesh Krishnamurthy whose telephone number is 571-272-3225. Papers related to this application may be submitted to Licensing and Review by facsimile transmission. The fax number for Licensing and Review is 571-270-9959. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /Daniel Pihulic/ Primary Examiner Art Unit 3645
Read full office action

Prosecution Timeline

Nov 08, 2019
Application Filed
Sep 09, 2021
Non-Final Rejection — §Other
Feb 07, 2022
Applicant Interview (Telephonic)
Feb 08, 2022
Examiner Interview Summary
Feb 14, 2022
Response Filed
Jul 25, 2022
Request for Continued Examination
Aug 02, 2022
Response after Non-Final Action
Sep 30, 2025
Final Rejection — §Other
Apr 02, 2026
Response after Non-Final Action

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12601422
MONITORING AN OPERATING CONDITION OF AN HVAC FLOW REGULATOR
2y 5m to grant Granted Apr 14, 2026
Patent 12601851
SYSTEMS AND METHODS FOR IN-SITU CHARACTERIZATION OF PERMAFROST SITES
2y 5m to grant Granted Apr 14, 2026
Patent 12596171
APPARATUSES, METHODS AND COMPUTER PROGRAMS FOR LOCATING MOBILE DEVICES BY USING PHOTOACOUSTICALLY-GENERATED AUDIO SIGNALS
2y 5m to grant Granted Apr 07, 2026
Patent 12594580
Altering and Enhancing Resonator Performances Using Free to Fixed Boundary Ratio (FFBR) Topology
2y 5m to grant Granted Apr 07, 2026
Patent 12596185
ROBUST VIRTUAL SENSOR
2y 5m to grant Granted Apr 07, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

AI Strategy Recommendation

Get an AI-powered prosecution strategy using examiner precedents, rejection analysis, and claim mapping.
Powered by AI — typically takes 5-10 seconds

Prosecution Projections

3-4
Expected OA Rounds
87%
Grant Probability
80%
With Interview (-6.7%)
2y 6m
Median Time to Grant
Moderate
PTA Risk
Based on 1004 resolved cases by this examiner. Grant probability derived from career allow rate.

Sign in for Full Analysis

Enter your email to receive a magic link. No password needed.

Free tier: 3 strategy analyses per month